{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:12:12Z","timestamp":1793747532895,"version":"4.6.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/ico.0b013e3181b1c82f","type":"journal-article","created":{"date-parts":[[2010,1,14]],"date-time":"2010-01-14T02:51:53Z","timestamp":1263437513000},"page":"192-196","source":"Crossref","is-referenced-by-count":31,"title":["The Effect of Subconjuctival Combined Treatment of Bevacizumab and Triamcinolone Acetonide on Corneal Neovascularization in Rabbits"],"prefix":"10.1097","volume":"29","author":[{"given":"Seungbum","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210204","first-page":"2485","article-title":"Loss and restoration of immune privilege in eyes with corneal neovascularization.","volume":"37","author":"Dana","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-14-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization.","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"R3-14-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review.","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"R4-14-20210204","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","article-title":"Corneal neovascularization. Pathogenesis and inhibition.","volume":"6","author":"Epstein","year":"1987","journal-title":"Cornea"},{"key":"R5-14-20210204","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","article-title":"A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.","volume":"230","author":"Crum","year":"1985","journal-title":"Science"},{"key":"R6-14-20210204","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topical application of methotrexate for inhibition of corneal angiogenesis.","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-14-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archopht.1992.01080150103037","article-title":"Suppression of corneal neovascularization with cyclosporine.","volume":"110","author":"Lipman","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R8-14-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/exer.1998.0512","article-title":"The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.","volume":"67","author":"Benelli","year":"1998","journal-title":"Exp Eye Res"},{"key":"R9-14-20210204","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis.","volume":"91","author":"DAmato","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-14-20210204","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0002-9394(79)90245-9","article-title":"Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas.","volume":"87","author":"Deutsch","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"R11-14-20210204","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bjo.87.8.1010","article-title":"Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.","volume":"87","author":"Sonoda","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R12-14-20210204","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","article-title":"Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy.","volume":"20","author":"Peyman","year":"2000","journal-title":"Retina"},{"key":"R13-14-20210204","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.","volume":"132","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R14-14-20210204","first-page":"2104","article-title":"Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.","volume":"2099-","author":"Danis","year":"103","journal-title":"Ophthalmology"},{"key":"R15-14-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","article-title":"Inhibitory effect of triamcinolone acetonide on corneal neovascularization.","volume":"244","author":"Murata","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-14-20210204","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00006982-200110000-00009","article-title":"Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy.","volume":"21","author":"Funatsu","year":"2001","journal-title":"Retina"},{"key":"R17-14-20210204","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0021-5155(01)00452-X","article-title":"Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema.","volume":"46","author":"Shimizu","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"R18-14-20210204","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"R19-14-20210204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(98)80005-1","article-title":"Signaling mechanisms through gp130: a model of the cytokine system.","volume":"8","author":"Hirano","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"R20-14-20210204","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4049\/jimmunol.172.2.1237","article-title":"CXCR2-\/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.","volume":"172","author":"Banerjee","year":"2004","journal-title":"J Immunol"},{"key":"R21-14-20210204","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00143085","article-title":"Animal experiment studies on the role of inflammation mediators in corneal neovascularization.","volume":"57","author":"Rochels","year":"1984","journal-title":"Doc Ophthalmol"},{"key":"R22-14-20210204","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exer.2005.05.001","article-title":"Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection.","volume":"82","author":"Biswas","year":"2006","journal-title":"Exp Eye Res"},{"key":"R23-14-20210204","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Eng J Med"},{"key":"R24-14-20210204","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularization by bevacizumab (Avastin).","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalomol"},{"key":"R25-14-20210204","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"R26-14-20210204","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R27-14-20210204","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).","volume":"27","author":"Kim","year":"2008","journal-title":"Cornea"},{"key":"R28-14-20210204","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02713680802607740","article-title":"The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas.","volume":"34","author":"Oh","year":"2009","journal-title":"Curr Eye Res"},{"key":"R29-14-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":"Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.","volume":"27","author":"Hurmeric","year":"2008","journal-title":"Cornea"},{"key":"R30-14-20210204","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e31817786ad","article-title":"Subconjunctival bevacizumab for corneal neovascularization.","volume":"27","author":"Doctor","year":"2008","journal-title":"Cornea"},{"key":"R31-14-20210204","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1167\/iovs.05-1651","article-title":"Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors.","volume":"47","author":"Ebrahem","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-14-20210204","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02713688508999984","article-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea.","volume":"4","author":"Mahoney","year":"1985","journal-title":"Curr Eye Res"},{"key":"R33-14-20210204","first-page":"449","article-title":"Inhibition of vascularization in rabbit corneas by heparin: cortisone pellets.","volume":"27","author":"Nikolic","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-14-20210204","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/archopht.1983.01040010640024","article-title":"Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization.","volume":"101","author":"Phillips","year":"1983","journal-title":"Arch Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICO.0b013e3181b1c82f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:58Z","timestamp":1786039798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201002000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3181b1c82f","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}